The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.
Open accessAbstract
We have chosen tumors of the uterine cervix as a model system to identify chromosomal aberrations that occur during carcinogenesis. A phenotype/genotype correlation was established in defined regions of archived, formalin-fixed, and hematoxylin/eosin-stained tissue sections that were dissected from normal cervical epithelium (n = 3), from mild (n = 4), moderate (n = 6), and severe dysplasias/carcinomas in situ (CIS) (n = 13), and from invasive carcinomas (n = 10) and investigated by comparative genomic hybridization. The same tissues were analyzed for DNA ploidy, proliferative activity, and the presence of human papillomavirus (HPV) sequences. The results show that an increase in proliferative activity and tetraploidization had occurred already in mildly dysplastic lesions. No recurrent chromosomal aberrations were observed in DNA extracted from normal epithelium or from mild and moderate dysplasias, indicating that the tetraploidization precedes the loss or gain of specific chromosomes. A gain of chromosome 3q became visible in one of the severe dysplasias/CIS. Notably, chromosome 3q was overrepresented in 90% of the carcinomas and was also found to have undergone a high-level copy-number increase (amplification). We therefore conclude that the gain of chromosome 3q that occurs in HPV16-infected, aneuploid cells represents a pivotal genetic aberration at the transition from severe dysplasia/CIS to invasive cervical carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Evolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 661
du Manoir, S., Speicher, M. R., Joos, S., Schröck, E., Popp, S., Döhner, H., Kovacs, G., Robert-Nicoud, M., Lichter, P., & Cremer, T. (1993) · Human Genetics · doi:10.1007/bf00202476 · Cited by 555
Self-citationFoulds, L. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90039-0 · Cited by 294
Quantitative analysis of comparative genomic hybridization
du Manoir, S., Schröck, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter, P., & Cremer, T. (1995) · Cytometry · doi:10.1002/cyto.990190105 · Cited by 293
Self-citationRied, T., Just, K., Holtgreve-Grez, H., du Manoir, S., Speicher, M. R., Schröck, E., Latham, C., Blegen, H., Zetterberg, A., & Cremer, T. (1995) · PubMed · Cited by 229
Self-citationRied, T., Petersen, I., Holtgreve-Grez, H., Speicher, M. R., Schröck, E., du Manoir, S., & Cremer, T. J. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)92204-7 · Cited by 207
Self-citationLoss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix.
Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sügimura, T., & Terada, M. (1989) · PubMed · Cited by 185
Schröck, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M.-C., Jauch, A. T., Speicher, M. R., Nürnberg, P., Vogel, S., & Jänisch, W. (1994) · PubMed Central · Cited by 176
Self-citationHampton, G. M., Penny, L. A., Baergen, R. N., Larson, A. A., Brewer, C. G., Liao, S., Busby-Earle, R., Williams, A. W., Steel, C. M., & Bird, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6953 · Cited by 150
ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra, A., Murty, V. V. V. S., Pratap, M., Sodhani, P., & Chaganti, R. S. K. (1994) · PubMed · Cited by 122
Chromosome changes in 43 carcinomas of the cervix uteri
Atkin, N. B., Baker, M. C., & Fox, M. F. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90052-c · Cited by 83
Hausen, H. Z. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90070-1 · Cited by 80
Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.
Srivatsan, E. S., Misra, B. C., Venugopalan, M., & Wilczynski, S. P. (1991) · PubMed · Cited by 59
Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines.
Jesudasan, R. A., Rahman, R., Chandrashekharappa, S., Evans, G. A., & Srivatsan, E. S. (1995) · PubMed · Cited by 48
Cytogenetics of cervical neoplasia
Popescu, N. C., & DiPaolo, J. A. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90024-3 · Cited by 10
Cited by
Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
Mechanisms of human papillomavirus-induced oncogenesis
Münger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., & Huh, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11451-11460.2004 · Cited by 815
The role of Notch in tumorigenesis: oncogene or tumour suppressor?
Radtke, F., & Raj, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1186 · Cited by 785
Context is everything: aneuploidy in cancer
Ben-David, U., & Amon, A. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0171-x · Cited by 665
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., & Zacny, V. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204860 · Cited by 588
Metadata
- Authors
- Heselmeyer, K., Schröck, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., & Ried, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-01-09
- Volume
- 93
- Issue
- 1
- Pages
- 479-484
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2003268750
- Cited by
- 468
- References
- 23
- FWCI
- 21.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.